Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Morris, E
Thomson, K
Craddock, C
Milligan, D
Smith, GM
Parker, A
Schey, S
Winfield, D
Chopra, R
Littlewood, T
Tighe, J
Hunter, A
Kyriakou, C
Kottaridis, P
Peggs, K
Linch, D
Goldstone, A
Mackinnon, S
机构：
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
139
引用
收藏
页码：40A / 40A
页数：1
相关论文
共 50 条
  • [31] A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant
    Laporte, JP
    Yeshurun, M
    Fouillard, L
    Labopin, M
    Cailliot, C
    Lesage, S
    Isnard, F
    Najman, A
    Gorin, NC
    LEUKEMIA, 2004, 18 (10) : 1717 - 1721
  • [32] Long-Term Follow-up of Survival in Hodgkin's Lymphoma.
    Canellos, George P.
    Niedzwiecki, Donna
    Johnson, Jeffrey L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24): : 2390 - 2391
  • [33] An unmet need for long-term follow-up in Hodgkin's lymphoma?
    Gisselbrecht, Christian
    LANCET HAEMATOLOGY, 2018, 5 (10): : E435 - E436
  • [34] A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa
    A G McCoy
    E P Smith
    M E Atkinson
    B Baranski
    B S Kahl
    M Juckett
    T Mitchell
    R Gangnon
    W L Longo
    Bone Marrow Transplantation, 2004, 33 : 19 - 24
  • [35] A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa
    McCoy, AG
    Smith, EP
    Atkinson, ME
    Baranski, B
    Kahl, BS
    Juckett, M
    Mitchell, T
    Gangnon, R
    Longo, WL
    BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 19 - 24
  • [36] Tailored therapy for aggressive non-Hodgkin's lymphoma: Results of a phase II study with a long-term follow-up
    Palmieri, G
    Morabito, A
    Rea, A
    Biondi, E
    Lauria, R
    Matano, E
    Pagliarulo, C
    Montesarchio, V
    Tagliaferri, P
    Bianco, AR
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (01) : 121 - 127
  • [37] Long term follow up of the patients with non-Hodgkin's Lymphoma treated with Rituximab in combination with CHOP regimen.
    Li, JM
    BLOOD, 2005, 106 (11) : 274B - 274B
  • [38] Campath-1H Induction in Adult Liver Transplantation: Long-Term Follow Up of 300 Patients
    Tryphonopoulos, P. T.
    Weppler, D.
    Nishida, S.
    Levi, D. M.
    Tekin, A.
    Selvaggi, G.
    Fan, J.
    Ruiz, P.
    Tzakis, A. G.
    TRANSPLANTATION, 2012, 94 (10) : 131 - 131
  • [39] Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H)
    Walsh, M.
    Chaudhry, A.
    Jayne, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (09) : 1322 - 1327
  • [40] Exploiting alloreactivity in relapsed and refractory Hodgkin Lymphoma: long-term follow-up of a T-cell-depleted reduced intensity transplant protocol
    Peggs, KS
    Thomson, K
    Hunter, A
    Chopra, R
    Mahendra, P
    Milligan, D
    Parker, A
    Pettengell, R
    Craddock, C
    Hale, G
    Waldmann, H
    Morris, EC
    Goldstone, AH
    Linch, DC
    Mackinnon, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 3 - 4
12345